TST Biomedical Electronics Co.

What TST Biomedical Electronics Co. does

TST Biomedical Electronics Co., Ltd. (tstbio, 嘉碩生醫電子股份有限公司) is a Taiwan-based privately-held developer of point-of-care diagnostic and health monitoring products built on proprietary Shear Horizontal Surface Acoustic Wave (SH-SAW) biosensor technology inherited from its parent company, Testech Technology Co., Ltd. (TST). The company's flagship iProtin platform is a compact handheld immunoassay reader (107mm x 73mm x 30mm, 185g) that delivers quantitative cardiovascular and inflammation biomarker results (CRP, Lp(a), ApoB, Albumin, Microalbumin) in under three minutes from only 5 µL of fingertip whole blood, using antigen-antibody interaction detection without enzymes or fluorescent labels. The product portfolio has expanded to include the iProték non-contact smart mattress (fiber optic sensing for elderly and long-term care monitoring) and the iPro-Lab clinical chemistry analyzer (microfluidic, full spectral analysis), with API integration capabilities connecting outputs to EMRs, health clouds, and wearable devices for companion diagnostics.

The company monetizes through a combined hardware-plus-consumables model: capital sales of iProtin readers, iPro-Lab analyzers, and iProték mattresses, supplemented by recurring single-use assay cartridges and reagent trays, plus OEM/ODM manufacturing services for biosensor chips supplied to academic and enterprise clients. Pricing is quote-based and not publicly disclosed; commercial expansion runs through authorized regional distributors (CoaChrom in DACH, Avant Medical in BENELUX, CORPORACION LYACOS in Peru), international medical exhibitions (ADLM, MEDICA, Medical Japan, Medical Fair Thailand), and a direct-to-consumer channel for the iProtin Home Use Series. The company holds ISO 13485 certification, EU CE marking, US FDA listing, multiple TFDA approvals, and Latin American regulatory clearances (ANVISA, INVIMA, DIGEMID), and has received recognition including the 2025 Taipei Biotech Gold Award, 2024 Taiwan Excellence Award, 2023 National Pharmaceutical Science R&D Award, and the 18th National Innovation Award.

Name

TST Biomedical Electronics Co.

Legal name

tst biomedical electronics Co., Ltd.

Website

https://tst.bio

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

TST Biomedical Electronics (tstbio) is a Taiwan-based developer of point-of-care diagnostic devices built on proprietary SH-SAW biosensor technology, serving clinical labs, hospitals, long-term care facilities, and home healthcare users with rapid cardiovascular and inflammation biomarker testing.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics (Point-of-Care Testing)

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB)

akta.pro secondary industries

Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK), Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL), Chronic Disease Remote Monitoring (COPD/CHF/HTN, Weight & Symptom Tracking) (HLAHACAI)

Keywords

• Point-of-care diagnostics
• Biosensor immunoassay
• Clinical chemistry analyzers
• Cardiovascular biomarker testing
• In vitro diagnostics

Headquarters

HQ city

Taoyüan

HQ country

Taiwan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic Instruments (Hardware Sales): Sale of iProtin immunoassay readers (BT version), iPro-Lab clinical chemistry analyzers, and iProték smart mattresses as capital equipment. Professional series and home-use series products sold as instruments.
2. Assay Cartridges and Reagents (Consumables): Recurring sales of single-use assay cartridges and reagent trays for iProtin (CRP, Lp(a), ApoB, Albumin, Microalbumin) and iPro-Lab (liver function, kidney function, lipid panels, HbA1c, etc.). Creates recurring revenue through consumable replenishment.
3. OEM/ODM Manufacturing Services: End-to-end manufacturing services for biosensor chips, from wafer processing to final diagnostic chip production. Flexible OEM/ODM collaboration for chip design, packaging modules, and bio-coating strategies supporting academic institutions, startups, and enterprise clients.

Pricing tiers

Go-to-market motion3 records

Distribution channels6 records

Marketing channels6 records

Core offering

TST Biomedical Electronics (tstbio) develops and manufactures point-of-care diagnostic instruments and consumables built on proprietary Shear Horizontal Surface Acoustic Wave (SH-SAW) biosensor technology. Its flagship iProtin platform detects cardiovascular, inflammatory, and kidney disease biomarkers from 5 µL of fingertip blood in under 3 minutes, complemented by the iPro-Lab clinical chemistry analyzer and the iProték non-contact smart mattress for elderly care monitoring.

Product overview

TST Biomedical Electronics Co. (tstbio) offers a comprehensive diagnostic and health monitoring portfolio built on proprietary Surface Acoustic Wave (SAW) biosensor technology. The product lineup centers on the iProtin platform, a next-generation point-of-care testing system available in Professional and Home Use series. Key offerings include: (1) iProtin Reader (BT ver.) - a handheld immunoassay analyzer with Bluetooth connectivity that delivers quantitative results in 3 minutes using 5 µL of fingertip blood; (2) iProtin Assay Cartridge Kits - including CRP, Lp(a), ApoB, Albumin, and Microalbumin cartridges for cardiovascular, inflammation, and kidney health monitoring; (3) iProték Smart Mattress - a non-contact monitoring system using fiber optic sensing for elderly and long-term care settings; and (4) iPro-Lab Clinical Chemistry Analyzer - a full spectral analysis system for clinical laboratory use supporting multiple biomarkers. All products are designed for rapid, accurate diagnostics at point-of-care with multiple regulatory certifications including FDA, TFDA, CE, and ISO 13485.

Differentiator

Problem solved

Functional benefit

Brands

• iProtin: Portable, laboratory-grade point-of-care immunoassay diagnostic platform using SH-SAW biosensor technology for cardiovascular and inflammatory biomarker detection.
• iProték
• iPro-Lab

Products and services

• iProtin Professional Series Point-of-care immunoassay platform for professional clinical settings, including the iProtin reader (BT ver.) and assay cartridge kits for CRP, Lp(a), ApoB, Albumin, and Microalbumin testing used in clinics, emergency departments, and preventive care.
• iProtin Home Use Series At-home version of the iProtin diagnostic platform featuring the iProtin reader and ApoB assay cartridge kit for personal cardiovascular risk monitoring with Bluetooth transmission of results to mobile devices.
• iProtin Reader (BT ver.) BMREDP0101 handheld immunoassay analyzer with Bluetooth connectivity that transmits test information to a mobile app, delivering quantitative results in 3 minutes from a 5 µL blood sample; 5-year lifetime or 3,000 measurements.
• iProtin CRP Assay Cartridge Kit TU0001A C-reactive protein analysis cartridge delivering results within 3 minutes from 5 µL of blood with linear range 0.2-10 mg/dL for evaluating acute or chronic inflammatory conditions.
• Lipoprotein(a) Assay Cartridge Set BMLPAP0110 Lipoprotein(a) analysis cartridge providing test results in 40 seconds from 5 µL of fingertip blood with linear range 8.3-140.2 mg/dL for cardiovascular disease risk assessment.
• ApoB Assay Kit BMAPB0110 / TU0009RA3000 Apolipoprotein B analysis cartridge producing results within 3 minutes from 5 µL of blood with linear range 8-202.2 mg/dL for cardiovascular disease risk diagnosis.
• Albumin Analysis Cassette Set BMALBP0110 / TU0014AA1003 albumin analysis cassette used as an aid in diagnosis of diseases involving the liver or kidneys and for nutritional status assessment.
• Microalbumin Analysis Cassette Set BMALBP0210 / TU0014BA5003 microalbumin analysis cassette using 200 µL of urine, serving as an indicator for diagnosing early stages of chronic kidney disease.
• iProték Smart Mattress Non-contact fiber optic smart mattress measuring heart rate (30-250 bpm), breathing (7-45 rpm), and body movement with over 95% accuracy versus clinical-grade contact sensors; designed for nursing homes, elderly care, and home healthcare with abnormal value alerts.
• iPro-Lab Clinical Chemistry Analyzer BPLPP00301 clinical chemistry analyzer using full spectral analysis and patented microfluidic chip technology, supporting multi-biomarker detection from serum, plasma, whole blood, and urine samples with detection times of 12-17 minutes and sample volumes of 0.06 mL or 0.14 mL.

Quantifiable outcome

• iProtin delivers quantitative results in under 3 minutes from 5 µL of fingertip whole blood
• +3 more outcomes

Named customers4 records

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature6 records

Partnerships

Four partnerships are on record, tiered core, regional and strategic.

• CoaChrom Diagnostica GmbHcoreChannel Partner/ Reseller/ Distributor · 1 January 2025CoaChrom Diagnostica GmbH is appointed as the authorized distributor for iProtin in the DACH region (Germany, Austria, Switzerland). Backed by CoaChrom's deep expertise in hemostasis diagnostics and strong regional distribution capabilities, iProtin will be more accessible to healthcare partners across these key European markets. The partnership enables cardiologists, clinical researchers, and distribution partners in the DACH region to access iProtin's rapid cardiovascular diagnostic solutions.
• Avant MedicalcoreChannel Partner/ Reseller/ Distributor · 1 January 2025Avant Medical is appointed as the authorized distributor for iProtin in the BENELUX region (Belgium, Netherlands, Luxembourg). With strong local expertise and a professional medical distribution network, Avant Medical will bring iProtin products closer to healthcare partners in these countries. The partnership supports the company's European market expansion strategy.
• CORPORACION LYACOSregionalChannel Partner/ Reseller/ Distributor · 1 January 2025CORPORACION LYACOS serves as tstbio's local partner in Peru for the XLVII International Internal Medicine Course 2025. On-site introduction and demonstration of iProtin to medical professionals, researchers, and industry partners from Latin America and the United States. Represents tstbio's entry into the Latin American market.
• Chang Gung University (Professor Wang Yongliang)strategicStrategic or Co-development Partner · 1 January 2021Industry-university collaboration with Professor Wang Yongliang of Chang Gung University, an authoritative scholar in Taiwan's biomedical field. Since 2020, jointly developed COVID-19 antibody detection chip reagents, respiratory syncytial virus (RSV), and human metapneumovirus (hMPV) detection products. Within one year, developed three product prototypes and published international papers. This collaboration contributed to winning the 18th National Innovation Award.

Scale indicators4 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• Boditech Med: Korea-based POCT specialist offering ichroma immunoassay readers and a broad cardiac/inflammation menu (CRP, hs-CRP, D-dimer, Troponin). Highly comparable because both target decentralized cardiovascular testing with compact immunoassay readers.
• Response Biomedical: Canadian POCT company with RAMP cardiovascular and infectious disease tests. Comparable because both sell rapid quantitative immunoassays into emergency and clinical settings using alternative detection architectures to mainstream chemiluminescence.
• EarlySense: Israel-based company offering under-mattress contactless patient monitoring (EverOn/Live) for heart rate, respiration, and motion in hospitals and elderly care. Directly comparable to iProték in target use case, technology approach, and care-facility customer base.
• PTS Diagnostics (CardioChek): US-based POCT manufacturer of CardioChek lipid and metabolic analyzers. Highly comparable because both offer handheld readers and consumable cartridges for cardiovascular risk assessment including lipids and inflammatory markers.
• EKF Diagnostics: UK-headquartered POCT and central lab diagnostics company with QuikRead and Stanbio product lines spanning CRP, HbA1c, and cardiac markers. Comparable because both target decentralized clinical testing with similar assay menus and small-footprint analyzers.

Emerging players

• Empatica: Digital health company with wearable biosensors and FDA-cleared monitoring for cardiac and respiratory signals. Comparable as a wearable/connected health monitoring peer in adjacent vital-sign and continuous-monitoring markets to iProték.

Broad incumbents

• Abbott: Global diagnostics giant with i-STAT and Afinion POCT platforms directly overlapping iProtin's clinical chemistry and immunoassay footprint. Comparable because both target point-of-care cardiovascular and infectious-disease biomarkers in hospitals and clinics.
• Siemens Healthineers: Major IVD vendor with Atellica and DCA Vantage POCT systems addressing cardiac and metabolic markers. Comparable because both sell into hospital central labs and clinical chemistry workflows competing for similar test volume.
• Roche Diagnostics: World-leading IVD provider with cobas and cardiac POCT assays (e.g., cobas h232) directly competing with iProtin's CRP, Lp(a), and ApoB panels. Comparable because both serve clinical laboratories and emergency departments with rapid cardiovascular diagnostics.
• QuidelOrtho: Specialty diagnostics company with broad POCT and immunoassay menu including Triage cardiac markers. Comparable because both compete in rapid cardiovascular biomarker testing at point of care.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@tstbio
• Facebookfacebook.com/tstbio2018
• LinkedInlinkedin.com/company/tst-biomedical-electronics-co-ltd

Compliance13 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TST Biomedical Electronics Co.